Since TLR9 is predominantly expressed in DCs, CpG-ODN, as an agonist of TLR9, induce Th1 and tumor-specific CTLs via endosome uptake and maturation of DCs (21, 22) as well as the secretion of IL-12 cytokine (23). The gene discussed is TLR9; the disease is neoplasm.